Abstract
Summary: A method is developed for the detection of homozygotes and heterozygote carriers of Niemanu-Pick disease type A by employing a high performance liquid chromatography (HPLC) technique for the measurement of sphingomyelin (SP) as well as for the assay of the enzyme sphingomyelinase (SPase) in skin fibroblasts and amniotic fluid cell cultures. A simple, less than 10-min, HPLC of the lipid extract of fibroblasts (about 2 × 106 cells) and measurement of the ratio of the area of SP peak to that of other phospholipids present in the cell-lipid extract show accumulation of SP in Niemann-Pick type A fibroblasts compared to normal. The SPase assay was performed by HPLC measurement of the substrate SP before and after hydrolysis by the enzyme. By employing this technique, it was shown that cells from patients with Niemann-Pick disease type A have less than 10% of the normal SPase activity, whereas the heterozygote carriers of this disease have about 50% of the normal activity.
Speculation: The HPLC method for the measurement of SP could be used for preliminary screening of a large number of samples suspected of Niemann-Pick disease. The diagnosis could be further confirmed by the actual SPase assay.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jungalwala, F., Milunsky, A. High Performance Liquid Chromatography for the Detection of Homozygotes and Heterozygotes of Niemann-Pick Disease. Pediatr Res 12, 655–659 (1978). https://doi.org/10.1203/00006450-197805000-00008
Issue date:
DOI: https://doi.org/10.1203/00006450-197805000-00008
